Siming Li
Impact in
- Oncology top 5%
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Biochemistry top 5%
Papers in
- Co-authors
- Xinan Sheng (59 shared papers)Lu Si (57 shared papers)Chuanliang Cui (56 shared papers)Zhihong Chi (49 shared papers)Bixia Tang (55 shared papers)Bin Lian (50 shared papers)Jun Guo (38 shared papers)Yan Kong (30 shared papers)
- Journals
- Journal of Clinical Oncology (26 papers)European Journal of Cancer (6 papers)Evidence-based Complementary and Alternative Medicine (3 papers)The Oncologist (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Siming Li
83 papers receiving 1.9k citations
Siming Li's Hit Papers
Peers
Comparison fields: 5 of 90
- Oncology 632
- Biochemistry 96
- Cancer Research 175
- Immunology 229
- Complementary and alternative medicine 77
Countries citing papers authored by Siming Li
This map shows the geographic impact of Siming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siming Li more than expected).
Fields of papers citing papers by Siming Li
This network shows the impact of papers produced by Siming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siming Li. The network helps show where Siming Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Siming Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1β Coactivation of SREBP Hit paper breakdown → | 2005 | 533 |
| 2 | 2013 | 130 | |
| 3 | 2021 | 96 | |
| 4 | 2019 | 54 | |
| 5 | 2016 | 53 | |
| 6 | 2015 | 50 | |
| 7 | 2014 | 40 | |
| 8 | 2018 | 39 | |
| 9 | 2017 | 37 | |
| 10 | 2018 | 37 | |
| 11 | 2018 | 37 | |
| 12 | 2022 | 37 | |
| 13 | 2021 | 36 | |
| 14 | 2022 | 35 | |
| 15 | 2013 | 34 | |
| 16 | 2020 | 33 | |
| 17 | 2020 | 30 | |
| 18 | 2022 | 30 | |
| 19 | 2011 | 30 | |
| 20 | 2017 | 29 |
About Siming Li
Siming Li is a scholar working on Oncology, Surgery, Molecular Biology, Pulmonary and Respiratory Medicine and Immunology, having authored 86 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (24 papers), Cutaneous Melanoma Detection and Management (21 papers), Bladder and Urothelial Cancer Treatments (15 papers), CAR-T cell therapy research (13 papers), Melanoma and MAPK Pathways (8 papers), Renal cell carcinoma treatment (6 papers), Immunotherapy and Immune Responses (6 papers) and Esophageal Cancer Research and Treatment (5 papers). The work is most often cited by research in Oncology (632 citations), Biochemistry (96 citations), Cancer Research (175 citations), Immunology (229 citations) and Complementary and alternative medicine (77 citations). Siming Li has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Xinan Sheng, Lu Si, Chuanliang Cui, Zhihong Chi, Bixia Tang, Bin Lian, Jun Guo, Yan Kong, Lili Mao and Jiandie D. Lin. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Evidence-based Complementary and Alternative Medicine, The Oncologist and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.